These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 9707304)

  • 41. Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.
    Sehgal SC; al Shaimy I
    Infection; 1994; 22(3):193-6. PubMed ID: 7927815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Moraxella (Branhamella) catarrhalis.
    Verghese A; Berk SL
    Infect Dis Clin North Am; 1991 Sep; 5(3):523-38. PubMed ID: 1955698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic resistance. Epidemiology of resistance--respiratory tract infections.
    Thomson CJ
    J Med Microbiol; 1997 Jun; 46(6):442-5. PubMed ID: 9379469
    [No Abstract]   [Full Text] [Related]  

  • 44. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
    Thornsberry C; Jones ME; Hickey ML; Mauriz Y; Kahn J; Sahm DF
    J Antimicrob Chemother; 1999 Dec; 44(6):749-59. PubMed ID: 10590275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
    Sahm DF; Jones ME; Hickey ML; Diakun DR; Mani SV; Thornsberry C
    J Antimicrob Chemother; 2000 Apr; 45(4):457-66. PubMed ID: 10747822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study.
    Thornsberry C; Sahm DF
    Chemotherapy; 2000; 46 Suppl 1():15-23. PubMed ID: 10810209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.
    Balder R; Shaffer TL; Lafontaine ER
    BMC Microbiol; 2013 Jun; 13():140. PubMed ID: 23782650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmid-mediated beta-lactamase in Branhamella catarrhalis.
    Kamme C; Eliasson I; Knutson BK; Vang M
    Drugs; 1986; 31 Suppl 3():55-63. PubMed ID: 3488198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.
    Manninen R; Huovinen P; Nissinen A
    J Antimicrob Chemother; 1997 Sep; 40(3):387-92. PubMed ID: 9338492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Moraxella catarrhalis endocarditis: case report and review of the literature.
    Stefanou J; Agelopoulou AV; Sipsas NV; Smilakou N; Avlami A
    Scand J Infect Dis; 2000; 32(2):217-8. PubMed ID: 10826914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in western Europe and in the USA. The Alexander Project Collaborative Group.
    Berk SL; Kalbfleisch JH
    J Antimicrob Chemother; 1996 Jul; 38 Suppl A():85-96. PubMed ID: 8858475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Hoban DJ; Doern GV; Fluit AC; Roussel-Delvallez M; Jones RN
    Clin Infect Dis; 2001 May; 32 Suppl 2():S81-93. PubMed ID: 11320449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China.
    Shi W; Wen D; Chen C; Yuan L; Gao W; Tang P; Cheng X; Yao K
    BMC Microbiol; 2018 Jul; 18(1):77. PubMed ID: 30029595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
    Zhanel GG; Karlowsky JA; Low DE; Hoban DJ
    J Antimicrob Chemother; 2000 May; 45(5):655-62. PubMed ID: 10797089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004).
    Deshpande LM; Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Oct; 44(10):3775-7. PubMed ID: 17021108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
    Yeo SF; Livermore DM
    J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media.
    Block SL
    Pediatr Infect Dis J; 1997 Apr; 16(4):449-56. PubMed ID: 9109158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Apr; 45(4):359-63. PubMed ID: 1518118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.